Know Cancer

or
forgot password

    • cancer clinical trials in houston, TX

    • Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy
    Dan L. Duncan Cancer Center at Baylor College of Medicine
    Houston, Texas 77030
    Bladder Cancer
    Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
    The Methodist Hospital Neurological Institute
    Houston, Texas 77030
    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma
    Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
    The University of Texas MD Anderson Cancer Center
    Houston, Texas 77030-4009
    Acute Myeloid Leukemia
    Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Diffuse Large Cell Lymphoma, Lymphoma
    Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
    University of Texas MD Anderson Cancer Center
    Houston, Texas 77030
    Rhabdomyosarcoma
    A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Carcinoma, Non-Small-Cell Lung
    Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    Thomas Street Health Center
    Lymphoma
    Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
    Texas Children's Cancer and Hematology Centers
    Houston, Texas 77030
    Neuroblastoma, Medulloblastoma
    Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Relapsed Multiple Myeloma
    Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Photopheresis for the Treatment of Acute Graft Versus Host Disease
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Graft Versus Host Disease
    Magnetic Resonance Imaging in Patients With Breast Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Advanced Cancer
    A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    T-cell Lymphomas, T-cell Leukemia, Sezary Syndrome, Mycosis Fungoides
    Laparoscopic Approach to Cervical Cancer
    M.D. Anderson Cancer Center

    Trial Locations
    M.D. Anderson Cancer Center
    Lyndon B. Johnson - MD Anderson Cancer Center
    Cervical Cancer
    Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Methodist Hospital
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Stage IV Pancreatic Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Breast Cancer
    Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
    The University of Texas M.D. Anderson Cancer Center
    Houston, Texas
    Chronic Lymphocytic Leukemia
    Screening for Familial Colorectal Cancer (CRC) Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Colorectal Cancer
    Lifestyle Intervention for Heart Failure
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Heart Failure
    Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
    UT MD Anderson Cancer Center

    Trial Locations
    UT MD Anderson Cancer Center
    LBJ General Hospital
    The Michael E. DeBakey V.A. Medical Center
    Advanced Cancer, Solid Tumors
    A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ
    Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Malignant Neoplasms of Brain
    CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
    St. Luke's Episcopal Hospital
    Houston, Texas 77030
    Non-small Cell Lung Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Methodist Hospital
    M D Anderson Cancer Center
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    T-cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Undergoing Donor Stem Cell Transplant
    Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital

    Trial Locations
    Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital
    Dan L. Duncan Cancer Center at Baylor College of Medicine
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Veterans Affairs Medical Center - Houston

    Trial Locations
    Veterans Affairs Medical Center - Houston
    Baylor University Medical Center - Houston
    Ben Taub General Hospital
    Leukemia
    Dasatinib in Resectable Malignant Pleural Mesothelioma
    UT MD . Anderson Cancer Center
    Houston, Texas 77030
    Malignant Pleural Mesothelioma
    Phase II R-ABVD Versus ABVD for Advanced Stage Classical Hodgkin Lymphoma
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Hodgkin Lymphoma
    Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
    MD Anderson Cancer Center

    Trial Locations
    MD Anderson Cancer Center
    Ben Taub General Hospital
    Critically Ill, Hyperglycemia
    Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
    The University of Texas, MD Anderson Cancer Center
    Houston, Texas 77030
    EGFR Inhibitor-associated Rash